DWT
CLB icon

Dorsey & Whitney Trust’s Core Laboratories CLB Stock Holding History

Dorsey & Whitney Trust’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,800
Closed -$207K – 527
2020
Q4 		$207K Sell
7,800
-31,208
-80% -$637K 0.02% 436
2020
Q3 		$595K Sell
39,008
-5,166
-12% -$108K 0.08% 205
2020
Q2 		$898K Sell
44,174
-9,457
-18% -$170K 0.13% 158
2020
Q1 		$555K Buy
53,631
+49
+0.1% +$1.37K 0.09% 185
2019
Q4 		$2.02M Buy
53,582
+24,160
+82% +$1.09M 0.27% 94
2019
Q3 		$1.37M Buy
29,422
+8,253
+39% +$384K 0.2% 111
2019
Q2 		$1.11M Buy
21,169
+2,319
+12% +$136K 0.17% 122
2019
Q1 		$1.3M Buy
18,850
+6,102
+48% +$409K 0.2% 108
2018
Q4 		$760K Buy
12,748
+10,807
+557% +$933K 0.13% 142
2018
Q3 		$225K Buy
+1,941
New +$219K 0.03% 356

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dorsey & Whitney Trust's CLB Position: Q1 2021 in Review

Dorsey & Whitney Trust sold out of Core Laboratories (CLB) in Q1 2021, closing a stake of 7,800 shares — an estimated $207K sold.

Dorsey & Whitney Trust first reported a position in CLB in Q3 2018 and held it in 10 quarters. The position peaked at $2.02M in Q4 2019. 183 funds tracked by Wall St. Rank hold CLB as of Q1 2021.

  • Dorsey & Whitney Trust reported no remaining Core Laboratories position as of Q1 2021 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 7,800 Core Laboratories shares in Q1 2021, an estimated $207K.
  • Dorsey & Whitney Trust first reported a position in Core Laboratories in Q3 2018 and held it in 10 quarters.
  • Dorsey & Whitney Trust's Core Laboratories position peaked at $2.02M in Q4 2019.
  • 183 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2021.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2021, filed 11 May 2021.